| ATPC 0.1158 65.43% | MTEN 0.0332 -5.95% | OCG 0.0099 -16.10% | SOXS 2.0697 -9.22% | AUID 1.9199 93.44% | CJMB 4.03 259.82% | IVP 0.0514 -37.32% | ZSL 2.8799 2.31% | NVDA 189.4801 3.46% | SLV 83.88 -0.80% | SPHL 16.86 649.33% | INTC 49.04 0.66% | ASST 0.9901 -3.87% | DVLT 0.745 3.73% | BNKK 4.175 50.18% | TZA 5.9265 -3.79% | APLT 0.1 0.10% | SOXL 60.8798 9.93% | TQQQ 55.4888 3.08% | BYND 1.0415 8.28% | GRAB 4.37 -5.62% | BBAI 6.4 2.24% | ONDS 13.575 0.11% | IBRX 3.9 29.14% | DUST 5.735 -1.04% | NVD 6.9084 -6.77% | TSLL 18.4101 1.88% | EEM 58.3301 1.00% | TSLS 5.135 -1.06% | BITO 13.315 -1.81% | DNN 3.551 1.75% | AAL 15.735 3.93% | PLUG 2.315 -1.49% | MSTX 4.93 -5.19% | SPY 694.945 0.66% | AMD 236.845 5.92% | JDST 2.075 -1.43% | NOK 6.715 5.58% | IBIT 54.45 -1.79% | RZLV 4.7555 17.13% | FNGD 5.375 -2.45% | SIDU 3.745 -0.13% | XLE 47.815 -0.51% | QQQ 625.95 1.03% | GPUS 0.2932 -8.63% | VALE 14.795 1.27% | TSM 344.39 5.28% | TSLA 443.57 0.99% | ACHR 9.215 3.42% | SQQQ 64.8865 -3.07%

Dexterra Group Inc. (HZNOF) Financial Performance Analysis

Dexterra Group Inc. (HZNOF), trading on the OTC market in the U.S. and primarily listed on the Toronto Stock Exchange (TSX: DXT), recently reported its financial results for the second quarter of 2025, ending June 30, 2025. The company announced an earnings per share (EPS) of $0.13, which fell slightly short of analyst expectations of $0.14. Additionally, its revenue of approximately $183.1 million missed the forecasted $259.4 million, indicating challenges in meeting market expectations.
 
The reported EPS of $0.13 reflects a minor shortfall of approximately 5% compared to estimates, suggesting potential pressures on profitability, such as higher costs or operational inefficiencies. The revenue miss, with actual sales of $183.1 million against an expected $259.4 million (a 29.4% shortfall), points to weaker-than-anticipated demand or project execution in Dexterra’s core segments, including facility management, workforce accommodations, and modular construction.
 
Dexterra’s financial metrics provide insight into its valuation and operational health:
  • Price-to-Sales (P/S) Ratio: Approximately 0.58, indicating that the market values Dexterra at a relatively low multiple of its revenue. This suggests the stock may be undervalued or reflects investor caution due to recent performance.
  • Enterprise Value-to-Sales (EV/S) Ratio: Approximately 0.68, showing the company’s total valuation (including debt) relative to revenue, reinforcing a modest market valuation.
  • Debt-to-Equity (D/E) Ratio: Approximately 0.36, reflecting a balanced capital structure with moderate debt levels relative to equity. This suggests financial prudence and manageable leverage.
  • Current Ratio: Approximately 1.34, indicating sufficient liquidity to cover short-term liabilities, supporting operational stability.
  • Enterprise Value-to-Operating Cash Flow (EV/OCF) Ratio: Approximately 9.02, highlighting how the market values Dexterra’s cash flow generation. A lower ratio suggests potential undervaluation relative to cash flow strength.
  • Earnings Yield: Approximately 5.41%, calculated as the inverse of the price-to-earnings (P/E) ratio of 18.47, indicating the earnings generated per dollar invested. This reflects moderate return potential despite the earnings miss.
The EPS and revenue shortfalls for HZNOF may stem from external factors, such as softened demand in energy or mining sectors, or internal challenges, like project delays or cost overruns.
 
The company’s low debt-to-equity ratio (0.36) and adequate current ratio (1.34) indicate resilience against short-term financial pressures. The EV/OCF ratio of 9.02 suggests that Dexterra generates strong cash flow relative to its valuation, which could appeal to value investors. The P/S ratio of 0.58 further supports the notion that the stock may be undervalued, though market sentiment may be tempered by the recent performance miss.
 
Dexterra Group Inc. (HZNOF) faced challenges in Q2 2025, with an EPS of $0.13 and revenue of $183.1 million (USD) missing estimates. Despite these shortfalls, the company’s strong liquidity, moderate debt, and favorable cash flow metrics suggest operational stability and potential undervaluation. Investors should monitor Dexterra’s upcoming quarters for signs of recovery in revenue growth and profitability, particularly in its high-demand Support Services segment. 
Published on: August 6, 2025